Selcaxen 40mg Capsule In Pakistan

Selcaxen 40mg Capsule In Pakistan

Selcaxen 40mg Capsule contains Selpercatinib 40mg, a selective RET kinase inhibitor. It is designed to target abnormal RET signaling involved in certain cancers. The product is listed by Pakistan’s Drug Regulatory Authority as Selcaxen 40mg Capsule containing Selpercatinib.

Selpercatinib is used for certain RET fusion-positive non-small cell lung cancers, RET-mutant medullary thyroid cancers, and other eligible RET-altered cancers depending on the patient’s diagnosis and approved treatment indication. Appropriate molecular testing is important before treatment.

Key Features

• Contains Selpercatinib 40mg
• Selective RET kinase inhibitor
• Used for certain RET-altered cancers
• Oral capsule formulation
• Prescription oncology medicine
• Requires specialist medical supervision

How to Use

Take Selcaxen exactly as prescribed by your oncologist. The appropriate dosage depends on factors such as body weight, diagnosis, other medicines and individual medical conditions. Capsules should be swallowed whole and should not be crushed or chewed.

Important Safety Information

Selcaxen 40mg is a prescription cancer medicine. Selpercatinib may cause or contribute to important adverse effects, including liver problems, high blood pressure and heart-rhythm abnormalities. Your doctor may therefore recommend regular monitoring during treatment.

Tell your doctor about all medicines and supplements you are taking because selpercatinib can interact with other medicines. Do not start, stop or change your dose without medical advice.

Why Choose Selcaxen 40mg?

Selcaxen 40mg provides selpercatinib in a convenient capsule form for patients who have an appropriate RET-altered cancer diagnosis. Because this is a specialized oncology medicine, treatment should be based on molecular testing and an oncologist’s treatment plan.